Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Cardiomyocytes from human induced pluripotent stem cells (hiPSC-CMs) are increasingly recognized as valuable for determining the effects of drugs on ion channels but they do not always accurately predict contractile responses of the human heart. This is in part attributable to their immaturity but the sensitivity of measurement tools may also be limiting. Measuring action potential, calcium flux or contraction individually misses critical information that is captured when interrogating the complete excitation-contraction coupling cascade simultaneously. Here, we develop an hypothesis-based statistical algorithm that identifies mechanisms of action. We design and build a high-speed optical system to measure action potential, cytosolic calcium and contraction simultaneously using fluorescent sensors. These measurements are automatically processed, quantified and then assessed by the algorithm. Multiplexing these three critical physical features of hiPSC-CMs allows identification of all major drug classes affecting contractility with detection sensitivities higher than individual measurement of action potential, cytosolic calcium or contraction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sala, L., van Meer, B. J., Tertoolen, L. G. J., Bakkers, J., Bellin, M., Davis, R. P., Denning, C., Dieben, M. A. E., Eschenhagen, T., Giacomelli, E., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312067 · Cited by 416
Self-citationSharma, A., Burridge, P. W., McKeithan, W. L., Serrano, R., Shukla, P., Sayed, N., Churko, J. M., Kitani, T., Wu, H., Holmström, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2584 · Cited by 404
Mannhardt, I., Eder, A., Dumotier, B., Prondzynski, M., Krämer, E., Traebert, M., Söhren, K.-D., Flenner, F., Stathopoulou, K., Lemoine, M. D., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx081 · Cited by 68
Self-citation
Research works printed but not linked: 52
- Braam, S. R. et al. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4, 107–116 (2010). · DOI · Paper page
- Blinova, K. et al. Comprehensive translational assessment of human induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias. Toxicol. Sci. 155, 234–247 (2016). · DOI · Paper page
- Colatsky, T. et al. The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative—Update on progress. J. Pharmacol. Toxicol. Methods 81, 15–20 (2016). · DOI · Paper page
- Redfern, W. S. et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58, 32–45 (2003). · DOI · Paper page
- Pointon, A. et al. Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes. Toxicol. Sci. 144, 227–237 (2014). · DOI · Paper page
- Bers, D. M. Cardiac excitation-contraction coupling. Nature 415, 198–205 (2002). · DOI · Paper page
- Birket, M. J. et al. Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function. Cell Rep. 13, 733–745 (2015). · DOI · Paper page
- Giacomelli, E. et al. Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells. Development 144, 1008–1017 (2017). · DOI · Paper page
- Pointon, A. et al. High-throughput imaging of cardiac microtissues for the assessment of cardiac contraction during drug discovery. Toxicol. Sci. 155, 444–457 (2016). · DOI · Paper page
- Mannhardt, I. et al. Human engineered heart tissue: analysis of contractile force. Stem Cell Rep. 7, 29–42 (2016). · DOI · Paper page
- van Meer, B. J., Tertoolen, L. G. J. & Mummery, C. L. Concise review: measuring physiological responses of human pluripotent stem cell derived cardiomyocytes to drugs and disease. Stem Cells 34, 2008–2015 (2016). · DOI · Paper page
- Ravens, U., Wettwer, E., Pfeifer, T., Himmel, H. & Armah, B. Characterization of the effects of the new inotropic agent BDF 9148 in isolated papillary muscles and myocytes of the guinea‐pig heart. Br. J. Pharmacol. 104, 1019–1023 (1991). · doi:10.1111/j.1476-5381.1991.tb12543.x
- Thomas, G., Chung, M. & Cohen, C. J. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent. Circ. Res. 56, 87–96 (1985). · doi:10.1161/01.res.56.1.87
- Fuerstenwerth, H. On the differences between ouabain and digitalis glycosides. Am. J. Ther. 21, 35–42 (2014). · DOI
- Cui, X.-L., Zhao, L.-Y. & Wu, B.-W. E-4031 enhanced Ca2+ transient and ventricular myocytes contraction via reverse mode Na+/Ca2+ exchange in normal and hypertrophic rats. Acta Pharmacol. Sin. 23, 797–802 (2002).
- Planelles-Herrero, V. J., Hartman, J. J., Robert-Paganin, J., Malik, F. I. & Houdusse, A. Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil. Nat. Commun. 8, 190 (2017). · DOI · Paper page
- Lohse, M. J., Engelhardt, S. & Eschenhagen, T. What is the role of beta-adrenergic signaling in heart failure? Circ. Res. 93, 896–906 (2003). · DOI · Paper page
- Knight, W. & Yan, C. Therapeutic potential of PDE modulation in treating heart disease. Future Med. Chem. 5, 1607–1620 (2013). · doi:10.4155/fmc.13.127
- Itzhaki, I. et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 6, e18037 (2011). · DOI · Paper page
- Zhao, L. & Zhang, B. Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. Sci. Rep. 7, 1–11 (2017). · DOI · Paper page
- Brack, K. E., Narang, R., Winter, J. & Andr, G. The mechanical uncoupler blebbistatin is associated with significant electrophysiological effects in the isolated rabbit heart. Exp. Physiol. 98, 1009–1027 (2013). · doi:10.1113/expphysiol.2012.069369
- Guo, L. et al. The electrophysiological effects of cardiac glycosides in cardiomyocytes and in guinea pig isolated hearts. Cell. Physiol. Biochem. 27, 453–462 (2011). · DOI
- Abrahamsson, C., Duker, G., Lundberg, C. & Carlsson, L. Electrophysiological and inotropic effects of H 234/09 (almokalant) in vitro: a comparison with two other novel IK blocking drugs, UK-68,798 (dofetilide) and E-4031. Cardiovasc. Res. 27, 861–867 (1993). · doi:10.1093/cvr/27.5.861
- Cherry, E. M. & Fenton, F. H. Suppression of alternans and conduction blocks despite steep APD restitution: electrotonic, memory, and conduction velocity restitution effects. Am. J. Physiol. Circ. Physiol. 286, H2332–H2341 (2004). · DOI · Paper page
- Zhang, M. et al. Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: Disease mechanisms and pharmacological rescue. Proc. Natl Acad. Sci. USA 111, E5383–E5392 (2014). · DOI · Paper page
- Sala, L. et al. A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. EMBO Mol. Med. 8, 1065–1081 (2016). · DOI · Paper page
- Knisley, S. B., Justice, R. K., Kong, W. & Johnson, P. L. Ratiometry of transmembrane voltage-sensitive fluorescent dye emission in hearts. Am. J. Physiol. Circ. Physiol. 279, H1421–H1433 (2000). · DOI
- Uzelac, I. & Fenton, F. H. Robust framework for quantitative analysis of optical mapping signals without filtering. in 2015 Computing in Cardiology Conference (CinC), Nice. 461–464 (IEEE, 2015). · doi:10.1109/cic.2015.7408686
- Bohm, M. et al. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ. Res. 68, 689–701 (1991). · DOI · Paper page
- Abi-Gerges, N. et al. Preservation of cardiomyocytes from the adult heart. J. Mol. Cell. Cardiol. 64, 108–119 (2013). · DOI
- Watanabe, H., Honda, Y., Deguchi, J., Yamada, T. & Bando, K. Usefulness of cardiotoxicity assessment using calcium transient in human induced pluripotent stem cell-derived cardiomyocytes. J. Toxicol. Sci. 42, 519–527 (2017). · DOI
- Mewes, T., Dutz, S., Ravens, U. & Jakobs, K. H. Activation of calcium currents in cardiac myocytes by empty β- adrenoceptors. Circulation 88, 2916–2922 (1993). · DOI
- Klimas, A. et al. Multimodal on-axis platform for all-optical electrophysiology with near-infrared probes in human stem-cell-derived cardiomyocytes. bioRxiv 10776, 10767–10776 (2018).
- Hortigon-Vinagre, M. P. et al. The use of ratiometric fluorescence measurements of the voltage sensitive dye Di-4-ANEPPS to examine action potential characteristics and drug effects on human induced pluripotent stem cell-derived cardiomyocytes. Toxicol. Sci. 154, 320–331 (2016). · DOI
- Christoph, J. et al. Electromechanical vortex filaments during cardiac fibrillation. Nature 555, 667–672 (2018). · DOI · Paper page
- Ruan, J.-L. et al. Mechanical Stress promotes maturation of human myocardium from pluripotent stem cell-derived progenitors. Stem Cells 33, 2148–2157 (2015). · DOI · Paper page
- Lemoine, M. D. et al. Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density. Sci. Rep. 7, 5464 (2017). · DOI · Paper page
- Sala, L., Ward-van Oostwaard, D., Tertoolen, L. G. J., Mummery, C. L. & Bellin, M. Electrophysiological analysis of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) using multi-electrode arrays (MEAs). J. Vis. Exp. e55587 (2017). · DOI
- Guo, L. et al. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell–derived cardiomyocytes. Toxicol. Sci. 123, 281–289 (2011). · DOI · Paper page
- Clements, M., Millar, V., Williams, A. S. & Kalinka, S. Bridging functional and structural cardiotoxicity assays using human embryonic stem cell-derived cardiomyocytes for a more comprehensive risk assessment. Toxicol. Sci. 148, 241–260 (2015). · DOI
- Maddah, M. et al. A non-invasive platform for functional characterization of stem-cell-derived cardiomyocytes with applications in cardiotoxicity testing. Stem Cell Rep. 4, 621–631 (2015). · DOI · Paper page
- Fürstenwerth, H. Ouabain—the insulin of the heart. Int. J. Clin. Pract. 64, 1591–1594 (2010). · DOI
- Shimoni, Y., Gotsman, M., Deutsch, J., Kachalsky, S. & Lichtstein, D. Endogenous ouabain-like compound increases heart muscle contractility. Nature 307, 369–371 (1984). · DOI
- Cleland, J. G. F. et al. The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: A double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet 378, 676–683 (2011). · DOI · Paper page
- Horváth, B. et al. Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes. Naunyn. Schmiedebergs. Arch. Pharmacol. 390, 1239–1246 (2017). · DOI
- Reyes, G., Schwartz, P. H., Newth, C. J. & Eldadah, M. K. The pharmacokinetics of isoproterenol in critically ill pediatric patients. J. Clin. Pharmacol. 33, 29–34 (1993). · DOI
- Molenaar, P. et al. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling. Naunyn. Schmiedebergs. Arch. Pharmacol. 375, 11–28 (2007). · DOI
- Singh, B. N., Ellrodt, G. & Peter, C. T. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs 15, 169–197 (1978). · DOI · Paper page
- Angus, J. A., Sarsero, D., Fujiwara, T., Molenaar, P. & Xi, Q. Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues. Clin. Exp. Pharmacol. Physiol. 27, 1019–1021 (2000). · doi:10.1046/j.1440-1681.2000.03369.x
- Giacomini, K. M., Massoud, N., Wong, F. M. & Giacomini, J. C. Decreased binding of verapamil to plasma proteins in patients with liver disease. J. Cardiovasc. Pharmacol. 6, 924–928 (1984). · doi:10.1097/00005344-198409000-00028
- Hanna, A. D., Lam, A., Tham, S., Dulhunty, A. F. & Beard, N. A. Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A. Mol. Pharmacol. 86, 438–449 (2014). · DOI · Paper page
- Temma, K. et al. Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart. Eur. J. Pharmacol. 234, 173–181 (1993). · doi:10.1016/0014-2999(93)90951-d
Cited by
Giacomelli, E., Meraviglia, V., Campostrini, G., Cochrane, A., Cao, X., van Helden, R. W. J., Krotenberg Garcia, A., Mircea, M., Kostidis, S., Davis, R. P., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.05.004 · Cited by 622
Self-citationMulti-chamber cardioids unravel human heart development and cardiac defects
(2023) · doi:10.1016/j.cell.2023.10.030 · Cited by 205
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration
Campostrini, G., Windt, L. M., van Meer, B. J., Bellin, M., & Mummery, C. L. (2021) · Circulation Research · doi:10.1161/circresaha.121.318183 · Cited by 96
Self-citationEngineering a living cardiac pump on a chip using high-precision fabrication
Michas, C., Karakan, M. Ç., Nautiyal, P., Seidman, J. G., Seidman, C. E., Agarwal, A., Ekinci, K., Eyckmans, J., White, A. E., & Chen, C. S. (2022) · Science Advances · doi:10.1126/sciadv.abm3791 · Cited by 82
Metadata
- Authors
- van Meer, B. J., Krotenberg, A., Sala, L., Davis, R. P., Eschenhagen, T., Denning, C., Tertoolen, L. G. J., & Mummery, C. L.
- Venue
- Nature Communications
- Published
- 2019-09-20
- Volume
- 10
- Issue
- 1
- Pages
- 4325-4325
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2973232024
- Cited by
- 73
- References
- 3
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/K000225/1)
- British Heart Foundation (SP/15/9/31605, RG/15/6/31436, PG/14/59/31000, RG/14/1/30588, P47352)
- RCUK | Medical Research Council (MR/M017354/1, G0801098)
- Heart Research UK (TRP01/12)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (024.003.001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes. https://app.cochat.ai/papers/10.1038/s41467-019-12354-8
- The paper
- van Meer, B. J., Krotenberg, A., Sala, L., Davis, R. P., Eschenhagen, T., Denning, C., Tertoolen, L. G. J., & Mummery, C. L. (2019). Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes. Nature Communications. https://doi.org/10.1038/s41467-019-12354-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.